21 CFR Part 630 · Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use

§ 630.30 Donation suitability requirements

Subpart B - Donor Eligibility Requirements Official text on eCFR Amendment history

(a) When is a donation suitable ? A donation is suitable when:

(1) The donor is not currently deferred from donation as determined by review of the records of deferred donors required under § 606.160(e) of this chapter ;

(2) The results in accordance with §§ 630.10 through 630.25 indicate that the donor is in good health and procedures were followed to ensure that the donation would not adversely affect the health of the donor;

(3) The results in accordance with § 630.10(e) indicate that the donor is free from risk factors for, or evidence of, relevant transfusion-transmitted infections and other factors that make the donor ineligible to donate;

(4) The donor's blood is tested in accordance with § 610.40 of this chapter , and is negative or nonreactive, unless an exception applies under § 610.40(h) of this chapter ; and

(5) The donation meets other requirements in this subchapter.

(b) What must you do when the donation is not suitable ?

(1) You must not release the donation for transfusion or further manufacturing use unless it is an autologous donation, or an exception is provided in this chapter.

(2) You must defer the donor when a donation is determined to be unsuitable based on the criteria in paragraphs (a)(1) through (4) of this section.

(3) You must defer the donor of bacterially contaminated platelets when the contaminating organism is identified in accordance with § 606.145(d) of this chapter as likely to be associated with a bacterial infection that is endogenous to the bloodstream of the donor.

(4) You must notify the deferred donor in accordance with the notification requirements in § 630.40 .

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

What FDA inspectors cite under § 630.30

Form FDA 483 observations citing this section, fiscal years 2016–2026 (Biologics).

  • Unsuitable donation - release 6
  • Unsuitable donation - defer testing 5
  • Donor medical history 5
  • Donation suitability 3
  • Donor health 1
  • Donor deferral 1

FDA guidance that cites § 630.30

Amendment history

Federal Register documents that created or amended this section.